Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival-Reference-Cited by-同舟云学术

Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival

Published:2019-02-07 Issue:4 Volume:18 Page:1842-1856
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Noel Brett M.¹²,Ouellette Steven B.²,Marholz Laura¹^ORCID,Dickey Deborah¹,Navis Connor¹,Yang Tzu-Yi¹,Nguyen Vinh¹,Parker Sarah J.³,Bernlohr David¹,Sachs Zohar⁴,Parker Laurie L.¹^ORCID

Affiliation:

1. Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, United States

2. Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907, United States

3. Smidt Heart Institute, Cedars Sinai, Los Angeles, California 90048, United States

4. Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.9b00028

Reference65 articles.

1. Heatmapper: web-enabled heat mapping for all

2. Chronic Myelogenous Leukemia

3. Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options

4. Present results and future perspectives in optimizing chronic myeloid leukemia therapy

5. Perspective: Combined forces

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment—Implications for Systemic Treatment;Cancers;2024-06-22

3. Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia;Cell Reports Medicine;2024-05

4. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia;Molecular Cancer;2023-11-06

5. Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells;PLOS ONE;2023-05-04